UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No.)

Filed by the Registrant [X]

Filed by a Party other than the Registrant [  ]

Check the appropriate box:

[  ]	Preliminary Proxy Statement
[  ]	Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[  ]	Definitive Proxy Statement
[X]	Definitive Additional Materials
[  ]	Soliciting Material Pursuant to § 240.14a-12

LIFEMD, INC.

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X]	No fee required.
[  ]	Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11.
(1)	Title of each class of securities to which transaction applies:
(2)	Aggregate number of securities to which transaction applies:
(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4)	Proposed maximum aggregate value of transaction:
(5)	Total fee paid:
[  ]	Fee paid previously with preliminary materials:
[  ]	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1)	Amount previously paid:
(2)	Form, Schedule or Registration Statement No.:
(3)	Filing Party:
(4)	Date Filed:

Additional Information Regarding LifeMD, Inc.’s Annual Meeting of Stockholders to be Held on June 24, 2021

On May 12, 2021, the Company filed a proxy statement (the “Definitive Proxy Statement”) that describes the proposals to be voted on at the Annual Meeting. On the proxy statement & notice of the meeting sent to stockholders there is a discrepancy on the sequence of two proposals to be voted on at the Annual Meeting. On the proxy statement & notice of the meeting, Proposal 4 pertains to the Say on Pay Frequency while Item 5 is the Ratification of Auditor. These two items have been switched on the original proxy card filed with the Definitive Proxy Statement. We are furnishing you with a revised proxy & notice of meeting herein.  Additionally, a revised proxy card matching the sequence of agenda items set forth in the Definitive Proxy Statement is also being mailed to stockholders.

The revised proxy statement and notice and revised proxy card are furnished herein. The updated proxy card is also being mailed to you separately and may be used to vote your shares.

You may also vote your shares on the voting website at www.proxyvote.com.

There are no other changes to the Definitive Proxy Statement previously filed. You may still refer to that statement to make your voting decisions.

Your vote remains extremely important, and we apologize for any inconvenience to you.

This supplement is being filed with the Securities and Exchange Commission on May 18, 2021 and will be mailed to stockholders on or before May 20, 2021.

This supplement should be read in conjunction with LifeMD, Inc.’s Definitive Proxy Statement filed with the Securities and Exchange Commission on May 12, 2021.